Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study

[1]  J. Cleland,et al.  Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease , 2018, The New England journal of medicine.

[2]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[3]  F. Zannad,et al.  Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges. , 2016, European heart journal.

[4]  Hanane Khoury,et al.  Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review , 2016, Cardiovascular therapeutics.

[5]  S. Dunlay,et al.  Multimorbidity in Older Patients with Cardiovascular Disease , 2016, Current Cardiovascular Risk Reports.

[6]  K. Huybrechts,et al.  Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation , 2015, Thrombosis and Haemostasis.

[7]  A. Gorst-rasmussen,et al.  Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. , 2015, JAMA.

[8]  C. Tournigand,et al.  Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  Piotr Ponikowski,et al.  Improving care for patients with acute heart failure: before, during and after hospitalization , 2014, ESC heart failure.

[10]  Deepak L. Bhatt,et al.  Nonobstructive coronary artery disease and risk of myocardial infarction. , 2014, JAMA.

[11]  C. Tribouilloy,et al.  Coronary artery disease and 10‐year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction , 2014, European journal of heart failure.

[12]  Akshay S. Desai,et al.  The role of coronary artery disease in heart failure. , 2014, Heart failure clinics.

[13]  G. Lip,et al.  Anticoagulation versus placebo for heart failure in sinus rhythm. , 2014, The Cochrane database of systematic reviews.

[14]  V. Wadley,et al.  Identifying a high stroke risk subgroup in individuals with heart failure. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  W. Klaskala,et al.  Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims. , 2013, Journal of cardiac failure.

[16]  F. Hobbs,et al.  Heart failure therapy in patients with coronary artery disease. , 2013, Current opinion in pharmacology.

[17]  D. Kitzman,et al.  Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management , 2012, Heart Failure Reviews.

[18]  G. Fonarow,et al.  Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. , 2011, The American journal of cardiology.

[19]  M. Rich,et al.  Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. , 2010, Journal of cardiac failure.

[20]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[21]  J. Dignam,et al.  Choice and interpretation of statistical tests used when competing risks are present. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Vasan,et al.  Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? , 2007, Cardiology clinics.

[23]  Haesook T. Kim.  Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.

[24]  E. Obi,et al.  Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts , 2016, Advances in Therapy.